本文關(guān)鍵詞：介入治療聯(lián)合清宮術(shù)治療123例剖宮產(chǎn)瘢痕妊娠的療效評價及臨床研究　出處：《實用婦產(chǎn)科雜志》2015年05期 　論文類型：期刊論文

  更多相關(guān)文章： 剖宮產(chǎn)瘢痕妊娠 介入治療 清宮術(shù)

【摘要】：目的:評估介入治療聯(lián)合清宮術(shù)治療剖宮產(chǎn)瘢痕妊娠(CSP)的安全性及有效性,為合理運用介入技術(shù)治療CSP提供臨床依據(jù)。方法:選擇于我院行介入治療聯(lián)合清宮術(shù)的CSP 123例,以介入治療前后血β-HCG及超聲影像學(xué)變化情況評價介入治療療效;并隨機將納入病例分為A組(n=72,介入術(shù)后5天內(nèi)清宮)和B組(n=51,介入術(shù)后5天以后清宮),比較兩組病例清宮術(shù)中大出血(出血量≥200 ml)發(fā)生率、住院時間等臨床結(jié)局。結(jié)果:123例納入病例中,介入治療48小時后血β-HCG開始下降的比例72.4%(89/123);胎心搏動消失率69.1%(38/55);切口處血流信號緩解率75.6%(59/78);清宮術(shù)中大出血發(fā)生率13.8%(17/123);住院時間平均8.3±2.9天。B組清宮術(shù)中大出血發(fā)生率及住院時間明顯高于A組,P均0.05。結(jié)論:介入治療能有效降低CSP組織活性、減少切口處血供,有助于增加清宮術(shù)中安全性。在介入治療聯(lián)合清宮術(shù)治療CSP中,介入治療與清宮術(shù)時間間隔的延長可能增加清宮術(shù)中出血風(fēng)險。
[Abstract]:Objective: to evaluate the safety and efficacy of interventional therapy combined with uterine clearance in the treatment of cesarean scar pregnancy. Methods: 123 cases of CSP who were treated with interventional therapy combined with uterine clearing in our hospital were selected to provide the clinical basis for the rational use of interventional technique in the treatment of CSP. The effect of interventional therapy was evaluated by the changes of blood 尾 -HCG and ultrasound imaging before and after interventional therapy. The patients were randomly divided into group A (n = 72) and group B (n = 51). The incidence of massive hemorrhage (bleeding volume 鈮，

本文編號：1424790